Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance

被引:3
作者
Alqualo, Nathalia Oliveira [1 ]
Campos-Fernandez, Esther [1 ]
Picolo, Bianca Uliana [1 ]
Ferreira, Emanuelle Lorrayne [1 ]
Henriques, Laila Machado [1 ]
Lorenti, Sabrina [1 ]
Moreira, Danilo Caixeta [1 ]
Simiao, Maria Paula Silva [1 ]
Oliveira, Luciana Beatriz Tiago [1 ]
Alonso-Goulart, Vivian [1 ,2 ]
机构
[1] Univ Fed Uberlandia, Inst Biotechnol, Lab Nanobiotechnol, Prof Dr Luiz Ricardo Goulart Filho, BR-38400902 Uberlandia, MG, Brazil
[2] Univ Fed Uberlandia, BR-996406010 Uberlandia, Brazil
关键词
Prostate cancer; Molecular markers; CTC; Metastatic cascade; Tumorigenesis; Metastasis; CIRCULATING TUMOR-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; INTERMEDIATE-FILAMENTS; SIGNALING PATHWAY; MESSENGER-RNA; MUTATIONS; ABIRATERONE; AR-V7; EXPRESSION; PROGNOSIS;
D O I
10.1016/j.critrevonc.2023.104232
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate cancer (PCa) is the second most frequent type of cancer in men and assessing circulating tumor cells (CTCs) by liquid biopsy is a promising tool to help in cancer early detection, staging, risk of recurrence evaluation, treatment prediction and monitoring. Blood-based liquid biopsy approaches enable the enrichment, detection and characterization of CTCs by biomarker analysis. Hence, comprehending the molecular markers, their role on each stage of cancer development and progression is essential to provide information that can help in future implementation of these biomarkers in clinical assistance. In this review, we studied the molecular markers most associated with PCa CTCs to better understand their function on tumorigenesis and metastatic cascade, the methodologies utilized to analyze these biomarkers and their clinical significance, in order to summarize the available information to guide researchers in their investigations, new hypothesis formulation and target choice for the development of new diagnostic and treatment tools.
引用
收藏
页数:21
相关论文
共 236 条
[71]  
Heninger E., 2016, Inducible expression of cancertestis antigens in human prostate cancer
[72]   TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy [J].
Heo, Kyun ;
Lee, Sukmook .
BIOMOLECULES, 2020, 10 (03)
[73]   Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer [J].
Hille, Claudia ;
Gorges, Tobias M. ;
Riethdorf, Sabine ;
Mazel, Martine ;
Steuber, Thomas ;
Von Amsberg, Gunhild ;
Konig, Frank ;
Peine, Sven ;
Alix-Panabieres, Catherine ;
Pantel, Klaus .
CELLS, 2019, 8 (09)
[74]   Multiparametric liquid biopsy analysis in metastatic prostate cancer [J].
Hodara, Emmanuelle ;
Morrison, Gareth ;
Cunha, Alexander ;
Zainfeld, Daniel ;
Xu, Tong ;
Xu, Yucheng ;
Dempsey, Paul W. ;
Pagano, Paul C. ;
Bischoff, Farideh ;
Khurana, Aditi ;
Koo, Samuel ;
Ting, Marc ;
Cotter, Philip D. ;
Moore, Mathew W. ;
Gunn, Shelly ;
Usher, Joshua ;
Rabizadeh, Shahrooz ;
Danenberg, Peter ;
Danenberg, Kathleen ;
Carpten, John ;
Dorff, Tanya ;
Quinn, David ;
Goldkorn, Amir .
JCI INSIGHT, 2019, 4 (05)
[75]   Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG [J].
Huaman, Jeannette ;
Ogunwobi, Olorunseun O. .
CELLS, 2020, 9 (07)
[76]   Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells [J].
Huaman, Jeannette ;
Naidoo, Michelle ;
Zang, Xingxing ;
Ogunwobi, Olorunseun O. .
CELLS, 2019, 8 (06)
[77]   SCRIB Is Involved in the Progression of Ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients [J].
Hussein, Usama Khamis ;
Ahmed, Asmaa Gamal ;
Choi, Won Ku ;
Kim, Kyoung Min ;
Park, See-Hyoung ;
Park, Ho Sung ;
Noh, Sang Jae ;
Lee, Ho ;
Chung, Myoung Ja ;
Moon, Woo Sung ;
Kang, Myoung Jae ;
Cho, Dong Hyu ;
Jang, Kyu Yun .
BIOMOLECULES, 2021, 11 (03) :1-18
[78]   Defining the region(s) of deletion at 6q16-q22 in human prostate cancer [J].
Hyytinen, ER ;
Saadut, R ;
Chen, CS ;
Paull, L ;
Koivisto, PA ;
Vessella, RL ;
Frierson, HF ;
Dong, JT .
GENES CHROMOSOMES & CANCER, 2002, 34 (03) :306-312
[79]  
Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI [10.1155/2014/357027, 10.1155/2014/852748]
[80]   Epithelial glycoprotein-2 expression is subject to regulatory processes in epithelial-mesenchymal transitions during metastases: an investigation of human cancers transplanted into severe combined immunodeficient mice [J].
Jojovic, M ;
Adam, E ;
Zangemeister-Wittke, U ;
Schumacher, U .
HISTOCHEMICAL JOURNAL, 1998, 30 (10) :723-729